Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.
Year: 2010
Type: article
Source: PubMed
Institution: Centre Hospitalier Universitaire Vaudois
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2184102596
